SCHEMBL9810

SCHEMBL9810

C=CCS(=O)(=O)OC(C)=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2337505 0.79
SCHEMBL11428385 0.79 ALDH1A1 (0.33) ALDH1A1
SCHEMBL902837 0.78
SCHEMBL11430477 0.77 ALDH1A1 (0.32) ALDH1A1
SCHEMBL8586144 0.77 ALDH1A1 (0.31) ALDH1A1
SCHEMBL2178902 0.77 MAPT (0.33)
SCHEMBL11667235 0.77 TSHR (0.37) ALDH1A1
SCHEMBL1644327 0.76 TSHR (0.35) ALDH1A1
SCHEMBL21823211 0.76 MAPT (0.32)
SCHEMBL11363845 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116234533-A Compositions and methods for cleansing keratin materials 欧莱雅 2023-06-06 CN disclosed
CN-106309421-B Pharmaceutical composition and cosmetic composition 沃凯索法株式会社 2020-08-25 CN disclosed
CN-111295205-A Deodorant-containing processing liquid, method for producing deodorant product, deodorant filter medium, deodorant filter unit, and deodorant device 东亚合成株式会社 2020-06-16 CN disclosed
US-20140364398-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents PFIZER INC. (US) 2014-12-11 US disclosed
US-8853258-B2 C-linked hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2014-10-07 US disclosed
EP-2488489-A2 C-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS Pfizer Inc. (US) 2012-08-22 EP disclosed
US-20120202777-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents BROWN MATTHEW FRANK (US) 2012-08-09 US disclosed
WO-2011045703-A2 C-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS PFIZER INC. (US) 2011-04-21 WO disclosed
CN-100383110-C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases DOMPE SPA (IT) 2008-04-23 CN disclosed
CN-1732145-A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases DOMPE SPA (IT) 2006-02-08 CN disclosed
CN-1163480-C Styryl sulfone anticancer agents ̹�ն���ѧ 2004-08-25 CN disclosed
CN-1433297-A Topical compositions comprising protected functional thiols PROCTER & GAMBLE (US) 2003-07-30 CN disclosed
CN-1273580-A Styryl sulfone anticancer agents UNIV TEMPLE (US) 2000-11-15 CN disclosed
CN-1110685-A Nitrogen-containing spiro ring MERCK & CO INC (US) 1995-10-25 CN disclosed
CN-1053613-A Nitrogen-containing spiro ring MERCK & CO INC (US) 1991-08-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202777-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents HAX1, LPXN, AGXT ALDH1A1 2127/4885
US-20140364398-A1 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents LCT, AGXT, PRXL2A ALDH1A1 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.